Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
Filing tables
Filing exhibits
Associated AMPE transcripts
AMPE similar filings
Filing view
External links
EXHIBIT 31.4
CERTIFICATION
I, Daniel G. Stokely, certify that:
1. I have reviewed this Amendment No. 1 to Annual Report on Form 10-K of Ampio Pharmaceuticals, Inc. for the year ended December 31, 2021; and
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
| /s/ Daniel G. Stokely |
| Daniel G. Stokely |
| Chief Financial Officer and Secretary |
|
|
Date: May 2, 2022 |
|